Hims & Hers Health Return on Tangible Equity 2020-2025 | HIMS

Current and historical return on tangible equity values for Hims & Hers Health (HIMS) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Hims & Hers Health Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-03-31 $0.16B $0.39B 53.51%
2024-12-31 $0.13B $0.32B 47.82%
2024-09-30 $0.10B $0.28B 42.62%
2024-06-30 $0.02B $0.23B 7.88%
2024-03-31 $0.00B $0.22B -1.47%
2023-12-31 $-0.02B $0.22B -12.26%
2023-09-30 $-0.04B $0.20B -19.28%
2023-06-30 $-0.05B $0.19B -25.86%
2023-03-31 $-0.06B $0.18B -33.24%
2022-12-31 $-0.07B $0.18B -36.02%
2022-09-30 $-0.09B $0.18B -45.74%
2022-06-30 $-0.08B $0.18B -41.97%
2022-03-31 $-0.07B $0.19B -32.11%
2021-12-31 $-0.11B $0.20B -42.93%
2021-09-30 $-0.08B $0.22B -49.69%
2021-06-30 $-0.07B $0.29B -64.55%
2021-03-31 $-0.06B $0.29B -162.58%
2020-12-31 $-0.02B $-0.15B 54.55%
2020-06-30 $-0.01B $0.01B -186.67%
2020-03-31 $-0.01B $0.01B -240.00%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $13.669B $1.477B
Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $45.989B 58.51
Tempus AI (TEM) United States $11.962B 0.00
IRhythm Technologies (IRTC) United States $4.646B 0.00
Inspire Medical Systems (INSP) United States $3.825B 59.77
Hinge Health (HNGE) United States $3.100B 0.00
Privia Health (PRVA) United States $2.659B 181.75
Enovis (ENOV) United States $1.751B 9.76
Schrodinger (SDGR) United States $1.545B 0.00
Phreesia (PHR) United States $1.527B 0.00
Clover Health Investments (CLOV) United States $1.511B 0.00
Azenta (AZTA) United States $1.371B 63.70
10x Genomics (TXG) United States $1.338B 0.00
Omnicell (OMCL) United States $1.324B 23.36
Claritev (CTEV) United States $0.663B 0.00
Fulgent Genetics (FLGT) United States $0.618B 0.00
Butterfly Network (BFLY) United States $0.534B 0.00
Veradigm (MDRX) United States $0.482B 0.00
Talkspace (TALK) United States $0.463B 138.50
Standard BioTools (LAB) United States $0.414B 0.00
Outset Medical (OM) United States $0.347B 0.00
TruBridge (TBRG) United States $0.346B 766.67
Nyxoah SA (NYXH) Belgium $0.263B 0.00
Health Catalyst (HCAT) United States $0.254B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.203B 0.00
KORU Medical Systems (KRMD) United States $0.150B 0.00
EUDA Health Holdings (EUDA) Singapore $0.139B 0.00
Pulmonx (LUNG) United States $0.111B 0.00
CareCloud (CCLD) United States $0.107B 4.06
American Well (AMWL) United States $0.106B 0.00
MDxHealth SA (MDXH) Belgium $0.096B 0.00
111 (YI) China $0.068B 0.00
HeartBeam (BEAT) United States $0.053B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.046B 0.00
P3 Health Partners (PIII) United States $0.045B 0.00
Zepp Health (ZEPP) Netherlands $0.035B 0.00
Zhongchao (ZCMD) China $0.031B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.016B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.011B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Movano (MOVE) United States $0.005B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Evaxion - (EVAX) Denmark $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.001B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00